Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
AssigneeTranscend Therapeutics, Inc.
InventorsBlake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
Life of this patent
Estimating the term…
Abstract
The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
Claims31
-70. (canceled)
A method of treating post-traumatic stress disorder (PTSD) or anxiety in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound, wherein the compound is methylone (3,4-methylenedioxy-N-methylcathinone) or a pharmaceutically acceptable salt thereof.
A method of treating post-traumatic stress disorder (PTSD) or anxiety in a human subject in need thereof, comprising orally administering to the subject a therapeutically effective amount of a compound, wherein
- the compound is methylone (3,4-methylenedioxy-N-methylcathinone) HCl;
- the therapeutically effective amount corresponds to 100-300 mg of methylone;
- and
- the therapeutically effective amount is administered weekly.
Dependencies are inferred from the claim text.